These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 19225323

  • 1. Compassionate use in research.
    Miracle VA.
    Dimens Crit Care Nurs; 2009; 28(2):85-8. PubMed ID: 19225323
    [Abstract] [Full Text] [Related]

  • 2. Clinical research and the development of new devices: considerations for nurses.
    Lanter J.
    Dimens Crit Care Nurs; 2007; 26(3):117-20. PubMed ID: 17440296
    [Abstract] [Full Text] [Related]

  • 3. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
    Ochs A.
    Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
    [No Abstract] [Full Text] [Related]

  • 4. Ethical issues of recruitment and enrollment of critically ill and injured patients for research.
    Richmond TS, Ulrich C.
    AACN Adv Crit Care; 2007; 18(4):352-5. PubMed ID: 17978608
    [No Abstract] [Full Text] [Related]

  • 5. The option of compassionate use in metastatic melanoma - way out of a therapeutic dilemma?
    Tsianakas A, Schiller M, Luger TA, Sunderkötter C.
    J Dtsch Dermatol Ges; 2009 Aug; 7(8):671-9. PubMed ID: 19708953
    [Abstract] [Full Text] [Related]

  • 6. Innovation to research: some transitional obstacles in critical care units.
    Morgenweck CJ.
    Crit Care Med; 2003 Mar; 31(3 Suppl):S172-7. PubMed ID: 12626964
    [No Abstract] [Full Text] [Related]

  • 7. Can single-patient investigational new drug studies hurry slow trains to the fast track?
    Chenoweth D.
    Drug Discov Today; 2006 Mar; 11(5-6):185-6. PubMed ID: 16580594
    [Abstract] [Full Text] [Related]

  • 8. Issues related to children participating in clinical research.
    Knox CA, Burkhart PV.
    J Pediatr Nurs; 2007 Aug; 22(4):310-8. PubMed ID: 17645958
    [Abstract] [Full Text] [Related]

  • 9. Caring for the silent patient.
    Benner P.
    Am J Crit Care; 2002 Sep; 11(5):480-1. PubMed ID: 12233974
    [No Abstract] [Full Text] [Related]

  • 10. Charging for investigational drugs under an investigational new drug application. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2009 Aug 13; 74(155):40871-900. PubMed ID: 19691172
    [Abstract] [Full Text] [Related]

  • 11. Should insurance be responsible for the cost of care while a patient is enrolled in a clinical trial?
    Weiss PA.
    Clin J Oncol Nurs; 2008 Feb 13; 12(1):153-4. PubMed ID: 18258585
    [No Abstract] [Full Text] [Related]

  • 12. Expanding access to investigational new therapies.
    Cohen C, Shevitz A, Mayer K.
    Prim Care; 1992 Mar 13; 19(1):87-96. PubMed ID: 1594704
    [Abstract] [Full Text] [Related]

  • 13. Expanded access to investigational drugs for treatment use. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2009 Aug 13; 74(155):40900-45. PubMed ID: 19691173
    [Abstract] [Full Text] [Related]

  • 14. Patient group seeks overhaul of FDA clinical trial system in court.
    Hede K.
    J Natl Cancer Inst; 2006 Sep 20; 98(18):1268-70. PubMed ID: 16985242
    [No Abstract] [Full Text] [Related]

  • 15. [Compassionate use of non-approved medicinal products. Legal basis and guidelines].
    Sudhop T.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr 20; 52(4):439-43. PubMed ID: 19343282
    [Abstract] [Full Text] [Related]

  • 16. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
    Schultheis LW, Rappaport BA.
    Anesth Analg; 2007 Mar 20; 104(3):479-80. PubMed ID: 17312189
    [No Abstract] [Full Text] [Related]

  • 17. No way to save a life: allowing terminally ill patients access to drugs that have not completed clinical trials is a dangerous move.
    Moss RW.
    New Sci; 2007 Mar 20; 190(2554):21. PubMed ID: 16832956
    [No Abstract] [Full Text] [Related]

  • 18. Food and Drug Administration responds to pressure for expanded drug access.
    Brower V.
    J Natl Cancer Inst; 2014 Jun 20; 106(6):dju171. PubMed ID: 24907387
    [No Abstract] [Full Text] [Related]

  • 19. Withdrawal of cardiac medications and devices.
    Wiegand DL, Kalowes PG.
    AACN Adv Crit Care; 2007 Jun 20; 18(4):415-25. PubMed ID: 17978616
    [Abstract] [Full Text] [Related]

  • 20. [Innovative drugs for the good of the patients].
    Dietrich W.
    Krankenpfl J; 2005 Jun 20; 43(4-6):136. PubMed ID: 16171078
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.